Metabolic and gut microbiome responses to personalized nutrition during metformin therapy in prediabetes and early‑stage type 2 diabetes: a randomized clinical trial
Zehra I. Uluturk; Anastasia Godneva; Sienna Walsh; Mallory Ledger; Eliza Chalmers; Jennifer R. Snaith; Tien-Ming Hng; Renee Richens; Krisztina Toth; Jennifer Evans; Jian Tan; Laurence Macia; Mark Danta; Eran Elinav; Eran Segal; Jerry R. Greenfield; Dorit Samocha-Bonet Current Treatment Options in Rheumatology
· Springer Nature
· 2026-11-19
Аннотация
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication for people with type 2 diabetes, but it does not always improve blood sugar levels. This study tests whether diet guidance, based on an individual’s data, could reduce blood sugar spikes after meals more than following a standard healthy diet. In this study, people starting metformin followed either a personalized diet or a standard low fat, high-fiber diet for six months. Both groups showed similar improvements in blood sugar, body weight, and health markers. The personalized diet reduced short-term blood sugar fluctuations slightly more, but the difference was small.
Zehra I. Uluturk; Anastasia Godneva; Sienna Walsh; Mallory Ledger; Eliza Chalmers; Jennifer R. Snaith; Tien-Ming Hng; Renee Richens; Krisztina Toth; Jennifer Evans; Jian Tan; Laurence Macia; Mark Danta; Eran Elinav; Eran Segal; Jerry R. Greenfield; Dorit Samocha-Bonet. Metabolic and gut microbiome responses to personalized nutrition during metformin therapy in prediabetes and early‑stage type 2 diabetes: a randomized clinical trial. // Current Treatment Options in Rheumatology. – 2026. – URL: https://www.nature.com/articles/s43856-026-02009-3
Zehra I. Uluturk; Anastasia Godneva; Sienna Walsh; Mallory Ledger; Eliza Chalmers; Jennifer R. Snaith; Tien-Ming Hng; Renee Richens; Krisztina Toth; Jennifer Evans; Jian Tan; Laurence Macia; Mark Danta; Eran Elinav; Eran Segal; Jerry R. Greenfield; Dorit Samocha-Bonet (2026). Metabolic and gut microbiome responses to personalized nutrition during metformin therapy in prediabetes and early‑stage type 2 diabetes: a randomized clinical trial. Current Treatment Options in Rheumatology. https://www.nature.com/articles/s43856-026-02009-3
Zehra I. Uluturk; Anastasia Godneva; Sienna Walsh; Mallory Ledger; Eliza Chalmers; Jennifer R. Snaith; Tien-Ming Hng; Renee Richens; Krisztina Toth; Jennifer Evans; Jian Tan; Laurence Macia; Mark Danta; Eran Elinav; Eran Segal; Jerry R. Greenfield; Dorit Samocha-Bonet. “Metabolic and gut microbiome responses to personalized nutrition during metformin therapy in prediabetes and early‑stage type 2 diabetes: a randomized clinical trial.” Current Treatment Options in Rheumatology, 2026.
@article{SamochaBonet2026,
title = {Metabolic and gut microbiome responses to personalized nutrition during metformin therapy in prediabetes and early‑stage type 2 diabetes: a randomized clinical trial},
author = {Samocha-Bonet, Zehra I. Uluturk; Anastasia Godneva; Sienna Walsh; Mallory Ledger; Eliza Chalmers; Jennifer R. Snaith; Tien-Ming Hng; Renee Richens; Krisztina Toth; Jennifer Evans; Jian Tan; Laurence Macia; Mark Danta; Eran Elinav; Eran Segal; Jerry R. Greenfield; Dorit},
journal = {Current Treatment Options in Rheumatology},
year = {2026},
url = {https://www.nature.com/articles/s43856-026-02009-3}
}
Purpose The engineered v5.9 DNA polymerase has been reported to exhibit enhanced thermostability in loop-mediated isothermal amplification (LAMP). As an initial step toward field-deployable molecular diagnosis of giardiasis, we...
Background Polygenic risk scores for cardiovascular disease show poor agreement between methods, and most treat sex as a covariate rather than stratifying by it, despite well-documented sex differences in disease incidence and outcomes....
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02013-7 The authors identify the mitochondrial RNA methyltransferase, NSUN4 as a potential therapeutic target in intrahepatic cholangiocarcinoma, with...
Cognitive tests are commonly used to evaluate the effects of cognitive and exercise interventions in Parkinson’s disease, but their ability to distinguish genuine change from measurement variability remains insufficiently characterized....
This study investigated whether asperuloside (ASP) regulates microglial metabolic reprogramming and polarization via AMPK signaling to protect dopaminergic neurons in Parkinson’s disease (PD). In LPS-stimulated BV-2 microglia, ASP...